Corneal transplantation improves bilateral vision in paediatric patients

Article

Corneal transplantation is generally successful in infants, children and adolescents

A recent study published in Ophthalmology shows corneal transplantation is generally successful in infants, children and adolescents.

Dr Keryn A. Williams et al., Department of Ophthalmology, Flinders Medical Centre, Australia, conducted a prospective cohort study on 14 865 records of penetrating corneal grafts in 11 929 patients. Of these records, 765 grafts in 640 patients aged 20 and below were used. Records from the Australian Corneal graft Registry were investigated using Kaplan-Meier survival plots and Cox proportional hazards regression analysis. The main outcome measures included the probability of corneal graft survival and Snellen acuity at certain intervals and at the last follow-up post-graft.

It was found that adolescents, of ages 13 to 19 years old, experienced the best corneal graft survival and infants, who were less than 5 years old, demonstrated the lowest corneal graft survival of all the study group. Factors influencing paediatric patient's corneal graft survival included indication for graft, graft inflammation, history of intraocular surgery, vascularization, rejection episodes, post-graft operative procedures and refractive surgery.

The findings suggested although overall bilateral vision is improved, infants showed low visual outcomes and it was concluded that both corneal graft survival and visual outcomes are affected more by graft indication than the patient's age.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.